Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares, requiring an investment of ₹14,820 at the upper price band. The IPO is expected to list on BSE and NSE on September 1, with allotment likely on August 28. At the upper band, the issue values the company at a steep 52 times FY26 diluted EPS.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.